你即將離開本站

並前往https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01324-6/fulltext

Efficacy and safety of a novel dual GIP and GLP-1 receptor ...

We did a 40-week, double-blind, randomised, placebo-controlled, phase 3 trial (SURPASS-1), at 52 medical research centres and hospitals in India ...

確定！ 回上一頁

查詢 「Surpass」的人也找了：

  1. surpass中文
    2.
  2. surpass公司
    3.
  3. surpass用法
    4.
  4. surpass接頭
    5.
  5. SURPASS-4
    6.
  6. surpass眼鏡
    7.
  7. surpass汽車
    8.
  8. How to pronounce surpass
    9.